Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
Search
Filter
3,361 - 3,380 of 15,249 Results
-
-
Missouri Tried to Fix Its Doctor Shortage. Now the Fix May Need Fixing.
Five states have created “assistant physician” licenses that allow medical school graduates to practice without completing residency training. But a federal indictment in Missouri of one assistant physician has some original supporters trying to rein in the medical specialty.
-
Long Waits for Montana State Hospital Leave Psychiatric Patients in Jail
A backlog at Montana’s psychiatric hospital for those facing criminal charges has left people with serious mental illness behind bars for months without adequate treatment. In some cases, judges have freed defendants over due-process violations.
-
How to Avoid Surprise Bills — And the Pitfalls in the New Law
The No Surprises Act offers protection from many surprise medical bills — but that protection may be only as good as a patient’s knowledge of the law and ability to make sure it’s enforced. Here’s what you need to know.
-
‘American Diagnosis’ Episode 5: A Fuller Moon Rising — Revised ‘Violence Against Women Act’ Offers Hope
The Violence Against Women Act (VAWA) was reauthorized on March 10, 2022, reaffirming tribes’ authority to prosecute non-Native perpetrators of sexual violence and certain other crimes. This episode looks at the history of VAWA, and how protections for Native women have been tangled in the fine print of the law.
-
Medicare Advantage Plans Send Pals to Seniors’ Homes for Companionship — And Profits
Many Medicare Advantage plans send caregivers to the homes of seniors periodically to help with housework and provide companionship. But the workers may also prod seniors into activities that boost the plans’ Medicare ratings and federal reimbursements.
-
‘An Arm and a Leg’: Need an Expensive Drug? Here’s What You Need to Know
Even a personal finance expert can get stuck with a huge unexpected bill for a drug. Listen up for what you need to know about "copay accumulators."
-
Want Vulnerable Californians to Have Healthier Pregnancies? Doulas Say the State Must Pay Up.
California was supposed to start paying doulas this year to help Medicaid enrollees have healthy pregnancies. But the benefit has been delayed because doulas feel lowballed by the state’s proposed reimbursement rate, which is below what most other states pay.
By Rachel Bluth -
Despite Seniors’ Strong Desire to Age in Place, the Village Model Remains a Boutique Option
Membership-based villages help arrange services for seniors — such as handyman help or transportation to appointments — and provide social connections through classes, leisure opportunities, or community events. Despite great promise, they have been slow to expand because of difficulties raising funding and keeping people interested.
-
Listen: An Unsettling Investigation Into the Closure of a Chain of Pain Clinics
KHN senior correspondents Jenny Gold and Anna Maria Barry-Jester joined KVPR’s Kathleen Schock on “Valley Edition” to discuss their investigation into the abrupt closure of one of California’s largest chain of pain clinics — and the patients left behind.
-
Listen: What We’ve Learned After Two Years of the Pandemic
KHN Editor-in-Chief Dr. Elisabeth Rosenthal joins the CNN podcast "Reliable Sources" and reflects on the societal trauma that covid-19 has wrought.
-
Pandemic Medical Innovations Leave Behind People With Disabilities
As the country enters Year 3 of the pandemic emergency, people with disabilities across the U.S. are still finding it difficult to use innovations in telemedicine, teleworking, and testing.
By Lauren Weber -
More Black Americans Are Buying Guns. Is It Driving Up Black Suicide Rates?
Gun buying among African Americans has soared in recent years. So have suicide rates among young Black men. Suicide prevention and gun safety efforts need to address race and cultural differences, Black gun owners say.
-
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Which Companies Aren’t Exiting Russia? Big Pharma
U.S. and global drug manufacturers invested in Russia’s sizable pharmaceutical industry contend international humanitarian law requires they continue manufacturing and selling their products there, even while condemning the Ukraine invasion. Not everyone agrees.
By Sarah Varney -
Listen
Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’
Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.
-
One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?
The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.
-
The CDC’s New Guidelines on Covid Risk and Masking Send Confounding Signals
The agency’s updated recommendations lower the level of covid risk for most of the country and therefore the need to mask. But some experts question the strategy.
-
The NFL Has Been Using an Unproven Measure to Get Players With Covid Back on the Field Fast
Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.
-
Patients Divided Over Alzheimer’s Drug: Is It a ‘Risk I’m Willing to Take’ or Just a ‘Magic Pill’?
Medicare has proposed limiting coverage of Aduhelm, the costly new drug to treat Alzheimer’s disease, and several prominent groups representing patients and their families are pressing the program to make it more widely available. But among individuals facing the disease, the outlook is more nuanced.